REDEFINE 1 the pivotal efficacy trial in adults with obesity without diabetes reported top-line results in early 2025
Report incorrect product information and get reward points.
The pattern fades by the fourth dose in most reports
[7] Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al
Nutrition 25(6):676685
Back Okunogbe, A, Nugent, R, Spencer, G, et al (Oct 2021) 'Economic impacts of overweight and obesity: current and future estimates for eight countries', British Medical Journal Global Health , 6/10, Back rskov, C, Bersani, M, Johnson, AH, et al (5 August 1989) 'Complete sequences of glucagon-like peptide-1 from human and pig small intestine', Journal of Biological Chemistry , 264/22, 12826-9